Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Planta Med ; 83(5): 398-404, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27124246

RESUMEN

Sesamol is a natural phenolic compound extracted from Sesamum indicum seed oil. Sesamol is endowed with several beneficial effects, but its use as a topical agent is strongly compromised by unfavorable chemical-physical properties. Therefore, to improve its characteristics, the aim of the present work was the formulation of nanostructured lipid carriers as drug delivery systems for topical administration of sesamol.Two different nanostructured lipid carrier systems have been produced based on the same solid lipid (Compritol® 888 ATO) but in a mixture with two different kinds of oil phase such as Miglyol® 812 (nanostructured lipid carrier-M) and sesame oil (nanostructured lipid carrier-PLUS). Morphology and dimensional distribution of nanostructured lipid carriers have been characterized by differential scanning calorimetry and photon correlation spectroscopy, respectively. The release pattern of sesamol from nanostructured lipid carriers was evaluated in vitro determining drug percutaneous absorption through excised human skin. Furthermore, an oxygen radical absorbance capacity assay was used to determine their antioxidant activity.From the results obtained, the method used to formulate nanostructured lipid carriers led to a homogeneous dispersion of particles in a nanometric range. Sesamol has been encapsulated efficiently in both nanostructured lipid carriers, with higher encapsulation efficiency values (> 90 %) when sesame oil was used as the oil phase (nanostructured lipid carrier-PLUS). In vitro evidences show that nanostructured lipid carrier dispersions were able to control the rate of sesamol diffusion through the skin, with respect to the reference formulations.Furthermore, the oxygen radical absorbance capacity assay pointed out an interesting and prolonged antioxidant activity of sesamol, especially when vehiculated by nanostructured lipid carrier-PLUS.


Asunto(s)
Antioxidantes/administración & dosificación , Benzodioxoles/administración & dosificación , Nanoestructuras , Vehículos Farmacéuticos , Fenoles/administración & dosificación , Administración Tópica , Adulto , Antioxidantes/farmacología , Benzodioxoles/química , Benzodioxoles/farmacología , Humanos , Técnicas In Vitro , Lípidos , Estructura Molecular , Tamaño de la Partícula , Fenoles/química , Fenoles/farmacología , Absorción Cutánea
2.
Curr Drug Deliv ; 13(1): 111-20, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26201345

RESUMEN

In this study, we evaluated different strategies to optimize the percutaneous absorption of niacinamide (NA) and soy phytosterols (FITO) by making use of solid lipid nanoparticles (SLN) and penetration enhancers, such as the hydrogenated lecithin. The evaluation of the skin permeation of NA and FITO has been effected in vitro using excised human skin (i.e., stratum corneum-epidermis or SCE). Furthermore, we evaluated the in vivo effect that NA and FITO has on skin barrier recovery after the topical application; using the extent of methyl nicotinate (MN)-induced erythema in damaged skin as a parameter to determine the rate of stratum corneum recovery. Results pointed out the importance of these strategies as valid tools for NA and FITO topical delivery. In fact, soy lecithin based formulations were able to increase the percutaneous absorption of the two active ingredients, while SLN guaranteed an interesting delayed and sustained release of FITO. In vivo evaluation showed clearly that the formulation containing both the actives (NA and FITO) is able to recover about 95% of skin barrier integrity eight days after tape stripping. This effect is probably due to the "synergistic effect" of NA and FITO.


Asunto(s)
Niacinamida/química , Niacinamida/metabolismo , Fitosteroles/química , Fitosteroles/metabolismo , Absorción Cutánea , Piel/metabolismo , Administración Tópica , Adulto , Química Farmacéutica/métodos , Portadores de Fármacos/química , Epidermis/metabolismo , Femenino , Humanos , Lecitinas/química , Lípidos/química , Masculino , Nanopartículas/química , Ácidos Nicotínicos/química , Permeabilidad
3.
J Cosmet Dermatol ; 13(2): 151-7, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24910279

RESUMEN

BACKGROUND: Exposure of the skin to solar ultraviolet (UV) radiations causes important oxidative damages that result in clinical and hystopathological changes, contributing to premature skin aging. Hyperpigmented lesions, also known as age spots, are one of the most visible alterations in skin photoaging. Skin is naturally equipped with antioxidant systems against UV-induced ROS generation; however, these antioxidant defenses are not completely efficient during exposure to sunlight. Oral antioxidants are able to counteract the harmful effects of UV radiation and to strengthen the physiological skin antioxidant defenses. AIMS: The present study was performed to evaluate the in vivo skin photo-protecting and anti-aging effects of a red orange (Citrus sinensis varieties Moro, Tarocco and Sanguinello) extract supplementation. Previous studies showed that red orange extracts possess strong in vitro free radical scavenging/antioxidant activity and photo-protective effects on human skin. MATERIALS/METHODS: The photo-protective effects of red orange extract intake against UV-induced skin erythema and melanin production in solar lentigo was evaluated on healthy volunteers by an objective instrumental method (reflectance spectrophotometry). RESULTS: Data obtained from in vivo studies showed that supplementation of red orange extract (100 mg/daily) for 15 days brought a significant reduction in the UV-induced skin erythema degree. Moreover, skin age spots pigmentation (melanin content) decreased from 27% to 7% when subjects were exposed to solar lamp during red orange extract supplementation. CONCLUSIONS: Red orange extract intake can strengthen physiological antioxidant skin defenses, protecting skin from the damaging processes involved in photo-aging and leading to an improvement in skin appearance and pigmentation.


Asunto(s)
Antioxidantes/uso terapéutico , Citrus sinensis , Lentigo/prevención & control , Extractos Vegetales/uso terapéutico , Traumatismos por Radiación/prevención & control , Envejecimiento de la Piel/efectos de los fármacos , Piel/efectos de los fármacos , Adulto , Suplementos Dietéticos , Eritema/etiología , Eritema/prevención & control , Humanos , Lentigo/etiología , Lentigo/metabolismo , Melaninas/biosíntesis , Persona de Mediana Edad , Fitoterapia , Piel/efectos de la radiación , Envejecimiento de la Piel/efectos de la radiación , Rayos Ultravioleta/efectos adversos
4.
J Cosmet Sci ; 64(5): 341-53, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24139433

RESUMEN

The aim of this study was to assess the ability of some vehicles (emulsion and emulgel), containing hydrogenated lecithin as penetration enhancer, in increasing the percutaneous absorption of the two model compounds dipotassium glycyrrhizinate (DG) and stearyl glycyrrhetinate (SG). Furthermore SG-loaded solid lipid nanoparticles (SLNs) were prepared and the effect of this vehicle on SG permeation profile was evaluated as well. Percutaneous absorption has been studied in vitro, using excised human skin membranes (i.e., stratum corneum epidermis or [SCE]), and in vivo, determining their anti-inflammatory activity. From the results obtained, the use of both penetration enhancers and SLNs resulted in being valid tools to optimize the topical delivery of DG and SG. Soy lecithin guaranteed an increase in the percutaneous absorption of the two activities and a rapid anti-inflammatory effect in in vivo experiments, whereas SLNs produced an interesting delayed and sustained release of SG.


Asunto(s)
Antiinflamatorios/farmacología , Ácido Glicirretínico/análogos & derivados , Ácido Glicirrínico/farmacología , Lecitinas/metabolismo , Administración Tópica , Adulto , Antiinflamatorios/metabolismo , Portadores de Fármacos , Emulsiones , Eritema/tratamiento farmacológico , Eritema/etiología , Eritema/patología , Femenino , Geles , Ácido Glicirretínico/metabolismo , Ácido Glicirretínico/farmacología , Ácido Glicirrínico/metabolismo , Humanos , Hidrogenación , Masculino , Nanopartículas , Tamaño de la Partícula , Permeabilidad , Piel/efectos de los fármacos , Piel/metabolismo , Piel/patología , Absorción Cutánea , Rayos Ultravioleta/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA